108 related articles for article (PubMed ID: 19230475)
1. Successful administration of cytarabine in a 16-month-old girl with acute myelogenous leukemia and cytarabine syndrome.
Metz KA; Johnson T; Hershey GK; Lierl MB; Seidu L; Burns K; Assa'ad A
Ann Allergy Asthma Immunol; 2009 Feb; 102(2):173-4. PubMed ID: 19230475
[No Abstract] [Full Text] [Related]
2. Idarubicin in acute leukemia: results of US trials.
Berman E; Raymond V; Gee TS; Kempin SJ; Gulati S; Andreeff M; Gabrilove J; Young CW; Clarkson BD; Wiernik PH
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():49. PubMed ID: 2713561
[No Abstract] [Full Text] [Related]
3. Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center.
Berman E; Raymond V; Gee T; Kempin SJ; Gulati S; Andreeff M; Kolitz J; Gabrilove J; Heller G; Young CW
Semin Oncol; 1989 Feb; 16(1 Suppl 2):30-4. PubMed ID: 2928808
[No Abstract] [Full Text] [Related]
4. Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
Clavio M; Venturino C; Pierri I; Garrone A; Miglino M; Canepa L; Balleari E; Balocco M; Michelis GL; Ballerini F; Gobbi M
Ann Hematol; 2004 Nov; 83(11):696-703. PubMed ID: 15322763
[TBL] [Abstract][Full Text] [Related]
5. [Myelodysplastic syndrome and myelogenous leukemia. Treatment with low-dose cytarabine].
Waage A; Hammerstrøm J; Lødemel B; Hoff JE; Langtind J
Tidsskr Nor Laegeforen; 1986 Feb; 106(6):496-7. PubMed ID: 3457484
[No Abstract] [Full Text] [Related]
6. High dose cytarabine in acute myelogenous leukemia.
Zittoun R
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():38-42. PubMed ID: 2653516
[No Abstract] [Full Text] [Related]
7. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
[TBL] [Abstract][Full Text] [Related]
8. Acute tumor lysis syndrome in a patient with chronic myelogenous leukemia in blast crisis: role of high-dose Ara-C.
Przepiorka D; Gonzales-Chambers R
Bone Marrow Transplant; 1990 Oct; 6(4):281-2. PubMed ID: 2085702
[TBL] [Abstract][Full Text] [Related]
9. Cytarabine-induced neurotoxicity responding to methyl prednisolone.
Malhotra P; Mahi S; Lal V; Kumari S; Jain S; Varma S
Am J Hematol; 2004 Dec; 77(4):416. PubMed ID: 15551283
[No Abstract] [Full Text] [Related]
10. Interferon-alpha and cytosine arabinoside therapy in chronic myeloid leukemia.
Ezaki K
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():279-84. PubMed ID: 10895166
[No Abstract] [Full Text] [Related]
11. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
12. [Update on malignant hematologic diseases].
Marie JP; Delmer A
Bull Cancer; 1998 Jan; 85(1):42-4. PubMed ID: 9752345
[No Abstract] [Full Text] [Related]
13. [A man with neutropenic fever].
Ham JC; Ruijs GJ; van Marwijk Kooy MR
Ned Tijdschr Geneeskd; 2013; 157(12):A5997. PubMed ID: 23515043
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute myeloid leukemia and myelodysplastic syndrome by low dose arabinosyl cytosine.
Baccarani M; Fasola G; Fanin R; Morassi P; Florean M; Pozzato G; Cavazzini G; Zaccaria A; Guarini L; Lodi L
Haematologica; 1985; 70(2):160-5. PubMed ID: 3924780
[No Abstract] [Full Text] [Related]
15. Does high-dose cytarabine cause cumulative toxicity in patients undergoing consolidation therapy for acute myeloid leukemia?
Wiernik A; Sperr WR; Weisdorf D; Valent P; Ustun C
Am J Hematol; 2013 Jun; 88(6):533-4. PubMed ID: 23526441
[No Abstract] [Full Text] [Related]
16. Cytarabine-associated lymphoid dyscrasia with atypical T CD30+ infiltrate in a patient suffering from acute nonlymphoblastic leukaemia.
Peñate Y; Guillermo N; Hernández-Machín B; Montenegro T; Borrego L
Br J Dermatol; 2009 May; 160(5):1122-3. PubMed ID: 19292713
[No Abstract] [Full Text] [Related]
17. Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).
Hackanson B; Rückert A; Lübbert M
Eur J Haematol; 2009 Dec; 83(6):611-2. PubMed ID: 19682063
[No Abstract] [Full Text] [Related]
18. Handling punctate keratitis resulting from systemic cytarabine.
Friedland S; Loya N; Shapiro A
Ann Ophthalmol; 1993 Aug; 25(8):290-1. PubMed ID: 8239322
[TBL] [Abstract][Full Text] [Related]
19. Jaundice following high--dose arabinoside cytosine in a child with acute myelogenous leukemia.
Wysocki M; Nowaczyk-Michalak A; Pilecki O; Trybuś L; Balcar-Boroń A
Acta Haematol Pol; 1992; 23(3):197-9. PubMed ID: 1492544
[TBL] [Abstract][Full Text] [Related]
20. A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment.
Janssen JJ; Berendse HW; Schuurhuis GJ; Merle PA; Ossenkoppele GJ
Am J Hematol; 2009 Oct; 84(10):679-82. PubMed ID: 19658186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
